Myasthenia gravis: open trials in Czechia

• NCT04951622

  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  MINKSneuro s.r.o., Brno · Vseobecna Fakultni Nemocnice V Praze, Prague 2

  Registry updated 2026-11-05

• NCT05374590

  Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

  Trial Treatment · Phase 2/3 · argenx

  Fakultni nemocnice Brno, Brno · Fakultni nemocnice Ostrava, Ostrava

  Registry updated 2026-11-03

• NCT07647510

  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  Trial Treatment · Phase 3 · Dianthus Therapeutics

  Fakultni nemocnice Ostrava, Ostrava · Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-30

• NCT06463587

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  Vseobecna Fakultni Nemocnice V Praze, Prague 2

  Registry updated 2026-10-21

• NCT06392386

  A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

  Trial Treatment · Phase 2/3 · argenx

  Fakultni nemocnice Brno, Brno · Fakultni nemocnice Ostrava, Ostrava

  Registry updated 2026-09-28

• NCT07039916

  Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Immunovant Sciences GmbH

  MINKSneuro s.r.o., Brno

  Registry updated 2026-07-30

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error